Patent details

Basic Information

Publication number:

EP3768711

PCT Application Number:

US2019022391

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP197140247

PCT Publication Number:

WO2019182878

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES

French Title of Invention:

ANTICORPS ANTI-CD137 POUR UNE COMBINAISON AVEC DES ANTICORPS ANTI-PD-L1

German Title of Invention:

ANTI-CD137-ANTIKÖRPER ZUR KOMBINATION MIT ANTI-PD-L1-ANTIKÖRPERN

SPC Number:

Dates

Filing date:

15/03/2019

Grant date:

03/05/2023

EP Publication Date:

27/01/2021

PCT Publication Date:

26/09/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/05/2023

EP B1 Publication Date:

03/05/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/03/2024

Expiration date:

15/03/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/04/2023

 

 

Name:

Eli Lilly and Company

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

1

Name:

CARPENITO, Carmine

Address:

United States (US)

2

Name:

LI, Yiwen

Address:

United States (US)

Priority

Priority Number:

201862647016 P

Priority Date:

23/03/2018

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202318

Publication date:

03/05/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages